I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 4 980 KRW -1.39% Market Closed
Market Cap: 178.8B KRW
Have any thoughts about
Isu Abxis Co Ltd?
Write Note
Isu Abxis Co Ltd
/
Balance Sheet
/
Retained Earnings

Isu Abxis Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Isu Abxis Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
I
Isu Abxis Co Ltd
KOSDAQ:086890
Retained Earnings
-₩124.5B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-17%
Celltrion Inc
KRX:068270
Retained Earnings
₩4T
CAGR 3-Years
12%
CAGR 5-Years
17%
CAGR 10-Years
17%
SK Bioscience Co Ltd
KRX:302440
Retained Earnings
₩549.4B
CAGR 3-Years
118%
CAGR 5-Years
127%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Retained Earnings
₩1T
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Retained Earnings
₩299.7B
CAGR 3-Years
32%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Retained Earnings
₩32.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Isu Abxis Co Ltd
Glance View

Market Cap
177.6B KRW
Industry
Biotechnology

ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 143 full-time employees. The company went IPO on 2009-02-03. The firm operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.

Intrinsic Value
8 552.29 KRW
Undervaluation 42%
Intrinsic Value
Price
I
What is Intrinsic Value?

See Also

What is Isu Abxis Co Ltd's Retained Earnings?
Retained Earnings
-124.5B KRW

Based on the financial report for Jun 30, 2024, Isu Abxis Co Ltd's Retained Earnings amounts to -124.5B KRW.

What is Isu Abxis Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
-17%

Over the last year, the Retained Earnings growth was -6%. The average annual Retained Earnings growth rates for Isu Abxis Co Ltd have been -4% over the past three years , -11% over the past five years , and -17% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.